"Vilprafen" is a broad-spectrum antibacterial agent that belongs to the macrolide group. The active components of the drug have a detrimental effect on a large number of pathogenic microorganisms.
The drug is made in tablet form for oral administration. Capsules are placed in blisters of ten pieces. Each tablet is coated with a white film shade and is at risk on one side.
The main active component of Vilprafen is josamycin in a dosage of five hundred milligrams, and a number of additional substances are also included in the preparation. "Vilprafen" treats ureaplasma.
Pharmacological actions
Tablets are prescribed for oral use in various bacterial diseases. The active component of "Vilprafen" adversely affects the sources of infection, inhibiting the process of protein bonding by bacteria. Josamycin has the ability to accumulate in the source of the lesion, thereby the medication has a powerful bactericidal effect.
The medicine is highly effective against streptococci, staphylococci, pneumococci, Helicobacter pylori, clostridia, peptococci, peptostreptococci. Perfectly eliminates "Vilprafen Solutab" ureaplasma, chlamydia and can be prescribed for the combined treatment of these diseases in gynecology and venereology.
After using the drug, orally active substances are rapidly absorbed through the membrane of the digestive system into the bloodstream. The maximum content of josamycin in the blood is observed a couple of hours after the use of the drug. The highest concentration of "Vilprafen" can be observed in humans in sweat, saliva, secretions, sperm, a tear, and bile.
Indications
This medicine is usually prescribed to patients to eliminate the following pathological conditions:
- Bronchitis (an inflammatory disease of the bronchi that affects the mucous cavity or the entire thickness of the wall of the bronchi).
- Pneumonia (inflammation of the lung tissue, usually of an infectious origin with a primary lesion of the alveoli and interstitial lung tissue).
- Pharyngitis (inflammation that develops in the pharynx, damaging its mucous cavity and deeper layers, lymph nodes).
- Sore throats (an infectious disease characterized by inflammation of the pharyngeal lymphadenoid ring).
- Tonsillitis (an infectious disease that affects one or more tonsils).
- Sinusitis (inflammation of the mucous membrane of one or more sinuses).
- Otitis (an ailment that is inflammation in the ear).
- Acute inflammation localized in the peri-almond fiber.
- Bronchopneumonia (is an acute inflammation of the walls of the bronchioles).
- Periodontal disease (deep damage to the posterior tissue).
- Gingivitis (gum disease without compromising the integrity of the gingival joint).
What other ailments can you take "Vilprafen"?
The medicine is used in the presence of the following diseases:
- Gumboil (purulent disease in the subgingival and submandibular jaw area).
- Prevention of the development of inflammation after tooth extraction.
- Boils (acute necrotic inflammatory process of the hair bulb, sebaceous gland and surrounding connective tissue caused by pyogenic bacteria, mainly Staphylococcus aureus).
- Carbuncle (purulent inflammatory process of the skin and subcutaneous tissue around the hair sacs and sebaceous glands, which tends to spread rapidly).
- Acne (a genetically determined disease).
- Pyoderma (purulent skin lesion resulting from the introduction of pyogenic cocci into it).
- Abscesses (infectious lesion of a separate area of the skin. During the period of maturation of the abscess, the symptoms intensify, the area becomes convex, accompanied by throbbing pain).
- Pustules (inflammatory skin disease).
- Erysipelas (a recurring infection provoked by beta-hemolytic streptococcus).
- Anthrax (an infectious disease of agricultural and wild animals of all species, as well as humans).
- Lymphadenitis (inflammation of the lymph nodes).
- Lymphogranulomatosis (hyperplasia of lymphoid tissue, which is characterized by the formation of granulomas with cells).
- Cystitis (an inflammatory process in the bladder).
- Urethritis (inflammation of the urethra caused by damage to the channel wall of various kinds of bacteria and viruses).
- Pyelonephritis (a non-specific inflammatory process with a predominant lesion of the tubular system of the kidney, mainly bacterial etiology).
- Prostate inflammation in men.
- Female gynecological disease affecting the fallopian tubes.
- Endometritis (an inflammatory process in the internal mucous layer of the uterus).
- Tsertsevit (damage to the mucous cavity of the cervical canal).
- Septic abortion (one of the serious complications of abortion, which develops, as a rule, under inpatient conditions in people with primary and secondary immunodeficiency).
- Gonorrhea (a specific infectious and inflammatory process that affects mainly the genitourinary system, the source of which are gonococci).
- Chlamydia (a group of acute and chronic infections caused by intracellular parasites in humans).
- Ureaplasmosis (an infectious disease of the genitourinary system that has a bacterial nature and is provoked by a pathogen called ureaplasma).
Contraindications
"Vilprafen" is prohibited for people to use in the presence of the following conditions:
- Individual intolerance to the components.
- Liver disease.
- Pregnancy.
- Lactation.
Method of using the drug
How to take "Vilprafen" with ureaplasma? The tablet should be taken orally, without chewing, washed down with water. The drug is usually prescribed after a meal or thirty minutes before it.
The dosage of the drug and the duration of therapy are determined by the doctor for each patient individually. It depends on the diagnosis, as well as the degree of the course of the infectious process, complications, age and weight.
According to the instructions for use with "Vilprafen 500" for ureaplasma, it is known that the maximum daily dosage for adults and adolescents from fourteen years old is from one to two grams, which must be divided into several consumption. In the initial stages of inflammation, provided there are no complications, adult patients are recommended to take one tablet twice a day.
The duration of treatment for different diseases will vary, but the medicine must be taken for at least five days, for a maximum of fourteen days.
In the absence of positive dynamics and improvements, the patient should definitely consult a medical specialist to clarify the diagnosis. Even if a person feels somewhat better, but the course of therapy is not yet completed, one cannot stop treatment with "Vilprafen" with ureaplasma.
With the early withdrawal of the drug, the inflammatory process will again make itself felt, but with greater force. Since the sources of infection will no longer be sensitive to the active substance, then the doctor will have to pick up a new medicine, stronger and in a larger dosage.
Is it possible to use "Vilprafen" during pregnancy with ureaplasma
According to reviews, it is known that medications from the macrolide group are not recommended for the treatment of women in an "interesting position".
The active components of Vilprafen can freely pass through the placental barrier, causing severe fetal damage. Pills during breastfeeding are prohibited.
If it is necessary to treat ureaplasma with "Vilprafen", a woman needs to interrupt lactation or consult a doctor for the selection of alternative therapy.
Adverse reactions
Subject to the dosage indicated in the instructions for use, Vilprafen is well tolerated by patients, but in rare cases the following negative effects may occur:
- Nausea.
- Pain in the abdomen.
- Hypersalivation (increased secretion of the salivary glands).
- Vomiting.
- "Indomitable" diarrhea.
- The development of the inflammatory process in the intestine.
- Jaundice (icteric staining of the skin and visible mucous cavities, which is caused by an increased concentration of bilirubin in the blood and tissues).
- Hives.
- Quincke's edema (a reaction to the effects of various biological and chemical factors, often of an allergic nature).
- Anaphylactic shock (an allergic reaction of an immediate type, a state of sharply increased sensitivity of the body).
Interaction
It is necessary to avoid the combination of "Vilprafen" with antibacterial agents from the group of penicillins or cephalosporins, as this can provoke the occurrence of severe liver damage, liver failure, diarrhea and dehydration. In difficult situations, a coma developed in patients.
With the combined use of antibacterial agents from the macrolide group with xanthines, an intoxication of the body arose in humans.
With the combination of "Vilprafen" with antihistamines, the development of serious lesions in the heart is likely.
With the joint use of Vilprafen tablets with hormonal oral contraceptives, their effectiveness may decrease, which should be warned by women. During antibiotic therapy, medical professionals recommend using condoms.
Features
According to reviews of "Vilprafen" with ureaplasma, it is known that people with retirement age, as well as patients with severe problems in the liver and kidneys, should take this drug with extreme caution. During therapy, it is necessary to periodically monitor the general state of health.
Analogs
The following medicines are related to substitutes for Vilprafen, which are similar in their pharmacological action:
- Erythromycin.
- "Azithromycin".
- Sumamed.
- Clarithromycin.
- Roxybide.
Storage conditions
The drug is dispensed at pharmacy points without a prescription from a doctor. Tablets must be kept out of reach of children, avoiding sun exposure. The optimum storage temperature should be no more than twenty-five degrees. Shelf life is thirty-six months. The average price of a drug varies from 450 to 680 rubles, depending on the point of sale.